TCRX
TScan Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
4.07 / 10Overall Score
NeturalInvestment Rating
4.07 / 10Overall Score
NeturalInvestment Rating
Trend Analysis of TCRX
- Based on a composite score of 4.07/10, we rate TCRX as a Netural. Our analysis breaks down into 4.58/10 for Fundamentals, 2.88/10 for Technicals, and 4.42/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of TCRX?
Is TCRX undervalued or overvalued?
Is money flowing into or out of TCRX?
Trend Analysis of TCRX
- Based on a composite score of 4.07/10, we rate TCRX as a Netural. Our analysis breaks down into 4.58/10 for Fundamentals, 2.88/10 for Technicals, and 4.42/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is TCRX undervalued or overvalued?
Technical Analysis of TCRX?
Is money flowing into or out of TCRX?
